Edition:
United Kingdom

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

3.85USD
23 Feb 2018
Change (% chg)

$0.10 (+2.67%)
Prev Close
$3.75
Open
$3.72
Day's High
$3.85
Day's Low
$3.68
Volume
53,615
Avg. Vol
109,829
52-wk High
$4.83
52-wk Low
$0.91

Select another date:

Fri, Feb 23 2018

BRIEF-Casi Pharmaceuticals Enters Into A Common Stock Sales Agreement With H.C. Wainwright & Co

* CASI PHARMACEUTICALS INC SAYS ENTERED INTO A COMMON STOCK SALES AGREEMENT WITH H.C. WAINWRIGHT & CO LLC - SEC FILING

BRIEF-CASI Pharma Board Approves Appointment Of Wei-Wu He As Executive Chairman

* CASI PHARMACEUTICALS - ON FEB 7, BOARD APPROVED APPOINTMENT OF WEI-WU HE, CURRENT CHAIRMAN OF BOARD, AS EXECUTIVE CHAIRMAN - SEC FILING Source text: (http://bit.ly/2EUtR7g) Further company coverage:

BRIEF-Casi Pharmaceuticals Files For Stock Shelf Of Upto $100 Million

* CASI PHARMACEUTICALS INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING Source text: [http://bit.ly/2zaieHQ] Further company coverage:

BRIEF-Casi pharmaceuticals Q3 loss per share $0.03

* Casi Pharmaceuticals reports third quarter 2017 financial results

BRIEF-CASI PHARMACEUTICALS ANNOUNCES $23.8 MLN REGISTERED DIRECT OFFERING

* CASI PHARMACEUTICALS ANNOUNCES $23.8 MILLION REGISTERED DIRECT OFFERING LED BY EXISTING SHAREHOLDERS

BRIEF-CASI provides pipeline development update

* CASI Pharmaceuticals Inc- CFDA has granted priority review for co's import drug registration clinical trial application for EVOMELA for injection Source text for Eikon: Further company coverage:

Select another date: